Capvizr
THE DEAL, AT A GLANCE

COUR Pharma

From the announcement
01What happenedCOUR Pharma raised $50M Series B, announced 2026-06-18From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersCOUR Pharma's $50M Series B is a mid-market Healthcare & Life Sciences financing in an active sector tape, with the round ranking at the 40th percentile while the…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

COUR Pharma · Financing Record

Explore source-linked visual explanations for COUR Pharma. Unsupported claims are withheld while source review continues.

Record 6236 · Recorded date: 2026-06-18

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime